|
Volumn 44, Issue 1, 1998, Pages 138-139
|
Incidence of exacerbations in the first 90 days of treatment with recombinant human interferon β-1b in patients with relapsing-remitting multiple sclerosis
a,b a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BETA INTERFERON;
CORTICOSTEROID;
METHYLPREDNISOLONE;
PREDNISONE;
ADULT;
ARTICLE;
CONTROLLED STUDY;
DISEASE COURSE;
DISEASE SEVERITY;
FEMALE;
HUMAN;
HUMAN TISSUE;
MAJOR CLINICAL STUDY;
MALE;
MULTIPLE SCLEROSIS;
PRIORITY JOURNAL;
RELAPSE;
RETROSPECTIVE STUDY;
STATISTICAL ANALYSIS;
TREATMENT INDICATION;
TREATMENT OUTCOME;
ADMINISTRATION, ORAL;
ADULT;
CASE-CONTROL STUDIES;
FEMALE;
GLUCOCORTICOIDS;
HUMANS;
INCIDENCE;
INJECTIONS, INTRAVENOUS;
INTERFERON-BETA;
MALE;
METHYLPREDNISOLONE;
MIDDLE AGED;
MULTIPLE SCLEROSIS;
NERVOUS SYSTEM DISEASES;
NEUROPROTECTIVE AGENTS;
PREDNISONE;
RECOMBINANT PROTEINS;
RECURRENCE;
RETROSPECTIVE STUDIES;
|
EID: 0031927091
PISSN: 03645134
EISSN: None
Source Type: Journal
DOI: 10.1002/ana.410440123 Document Type: Article |
Times cited : (17)
|
References (5)
|